Re: Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men

Journal of the National Cancer Institute

Volumn 95, Issue 7, 2003, Pages 559-560

  Sung, Ying Man ^a   Tang, Nelson Leung Sang ^a   Lai, Paul Bo San ^b   Chan, Paul Kay Sheung ^b   Chan, Francis Ka Leung ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; BIOCHEMICAL MARKER; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; CHOLESTENONE 5ALPHA REDUCTASE; DNA; OXIDOREDUCTASE; TUMOR MARKER;

CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENDER; GENE FREQUENCY; GENETIC CODE; GENETIC PREDISPOSITION; GENOTYPE; HEPATITIS B VIRUS; HOMOZYGOSITY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LETTER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VIRUS CARRIER; ADULT; AGED; ALLELE; ASIAN; BLOOD; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; HEPATITIS B; LEUKOCYTE; LIVER TUMOR; MIDDLE AGED; NOTE; TAIWAN; VIROLOGY;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHOLESTENONE 5 ALPHA-REDUCTASE; DNA, NEOPLASM; GENOTYPE; HEPATITIS B; HUMANS; LEUKOCYTES; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; TAIWAN; TESTOSTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037413953     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.7.559     Document Type: Letter

References (6)

1. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93: 1644-51.
2. Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993;53:790-4.
3. Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, et al. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2001;10:1077-82.
4. Makridakis NM, di Salle E, Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 2000;10:407-13.
5. Rapley R. Restriction fragment length polymorphism. In: Enayat MS, editor. The nucleic acid protocols handbook. Totowa (NJ): Humana Press; 2000. p. 679-85.
6. Schlesselman JJ, Stolley PD. Case-control studies: design, conduct, analysis. New York (NY): Oxford University Press; 1982. p. 684-97.